Fri, 11th Dec 2020 16:33
Dec 11 (Reuters) - The World Health Organization said on
Friday nearly 1 billion doses of leading vaccine candidates had
been secured as part of the COVAX programme to provide vaccines
for low- and middle-income countries.
Tedros Adhanom Ghebreyesus, WHO director-general, told a
Geneva news conference on Friday that 189 countries were
participating in the programme.
(Writing by Peter Graff; Editing by Catherine Evans)
(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...
(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.
(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...
(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...
(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...
Astrazeneca (AZN)